DE10235168A1 - Verfahren zur Reinigung von Preproinsulin - Google Patents

Verfahren zur Reinigung von Preproinsulin Download PDF

Info

Publication number
DE10235168A1
DE10235168A1 DE10235168A DE10235168A DE10235168A1 DE 10235168 A1 DE10235168 A1 DE 10235168A1 DE 10235168 A DE10235168 A DE 10235168A DE 10235168 A DE10235168 A DE 10235168A DE 10235168 A1 DE10235168 A1 DE 10235168A1
Authority
DE
Germany
Prior art keywords
gly
leu
glu
ser
gln
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10235168A
Other languages
German (de)
English (en)
Inventor
Horst Dr. Thurow
Hans Dr. Blumenstock
Chantalle Dr. Havenith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Priority to DE10235168A priority Critical patent/DE10235168A1/de
Priority to PT03766211T priority patent/PT1527097E/pt
Priority to AT03766211T priority patent/ATE384742T1/de
Priority to DK03766211T priority patent/DK1527097T3/da
Priority to PCT/EP2003/007820 priority patent/WO2004013176A1/de
Priority to SI200331119T priority patent/SI1527097T1/sl
Priority to AU2003254375A priority patent/AU2003254375B2/en
Priority to CA2493539A priority patent/CA2493539C/en
Priority to ES03766211T priority patent/ES2297223T3/es
Priority to DE50309087T priority patent/DE50309087D1/de
Priority to EP03766211A priority patent/EP1527097B1/de
Priority to MXPA05001042A priority patent/MXPA05001042A/es
Priority to JP2004525238A priority patent/JP4519646B2/ja
Priority to BR0313131-9A priority patent/BR0313131A/pt
Priority to US10/632,414 priority patent/US20050080000A1/en
Publication of DE10235168A1 publication Critical patent/DE10235168A1/de
Priority to IL166438A priority patent/IL166438A/en
Priority to US11/305,508 priority patent/US7803763B2/en
Priority to CY20081100198T priority patent/CY1108046T1/el
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
DE10235168A 2002-08-01 2002-08-01 Verfahren zur Reinigung von Preproinsulin Withdrawn DE10235168A1 (de)

Priority Applications (18)

Application Number Priority Date Filing Date Title
DE10235168A DE10235168A1 (de) 2002-08-01 2002-08-01 Verfahren zur Reinigung von Preproinsulin
DE50309087T DE50309087D1 (cg-RX-API-DMAC7.html) 2002-08-01 2003-07-18
EP03766211A EP1527097B1 (de) 2002-08-01 2003-07-18 Verfahren zur reinigung von preproinsulin
DK03766211T DK1527097T3 (da) 2002-08-01 2003-07-18 Fremgangsmåde til rensning af preproinsulin
PCT/EP2003/007820 WO2004013176A1 (de) 2002-08-01 2003-07-18 Verfahren zur reinigung von preproinsulin
SI200331119T SI1527097T1 (sl) 2002-08-01 2003-07-18 Postopek za ciscenje preproinzulina
AU2003254375A AU2003254375B2 (en) 2002-08-01 2003-07-18 Method for purifying preproinsulin
CA2493539A CA2493539C (en) 2002-08-01 2003-07-18 A method for purifying preproinsulin
ES03766211T ES2297223T3 (es) 2002-08-01 2003-07-18 Procedimiento para la purificacion de preproinsulina.
PT03766211T PT1527097E (pt) 2002-08-01 2003-07-18 Processo para a purificação de pré-proinsulina
AT03766211T ATE384742T1 (de) 2002-08-01 2003-07-18 Verfahren zur reinigung von preproinsulin
MXPA05001042A MXPA05001042A (es) 2002-08-01 2003-07-18 Un metodo para purificar preproinsulina.
JP2004525238A JP4519646B2 (ja) 2002-08-01 2003-07-18 プレプロインスリンの精製方法
BR0313131-9A BR0313131A (pt) 2002-08-01 2003-07-18 Processo para a purificação de preproinsulina
US10/632,414 US20050080000A1 (en) 2002-08-01 2003-08-01 Method of purifying preproinsulin
IL166438A IL166438A (en) 2002-08-01 2005-01-23 Method for purifying preproinsulin
US11/305,508 US7803763B2 (en) 2002-08-01 2005-12-15 Method of purifying preproinsulin
CY20081100198T CY1108046T1 (el) 2002-08-01 2008-02-18 Μεθοδος για τον καθορισμο προπροϊνσουλινης

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10235168A DE10235168A1 (de) 2002-08-01 2002-08-01 Verfahren zur Reinigung von Preproinsulin

Publications (1)

Publication Number Publication Date
DE10235168A1 true DE10235168A1 (de) 2004-02-12

Family

ID=30128614

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10235168A Withdrawn DE10235168A1 (de) 2002-08-01 2002-08-01 Verfahren zur Reinigung von Preproinsulin
DE50309087T Expired - Lifetime DE50309087D1 (cg-RX-API-DMAC7.html) 2002-08-01 2003-07-18

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE50309087T Expired - Lifetime DE50309087D1 (cg-RX-API-DMAC7.html) 2002-08-01 2003-07-18

Country Status (16)

Country Link
US (2) US20050080000A1 (cg-RX-API-DMAC7.html)
EP (1) EP1527097B1 (cg-RX-API-DMAC7.html)
JP (1) JP4519646B2 (cg-RX-API-DMAC7.html)
AT (1) ATE384742T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003254375B2 (cg-RX-API-DMAC7.html)
BR (1) BR0313131A (cg-RX-API-DMAC7.html)
CA (1) CA2493539C (cg-RX-API-DMAC7.html)
CY (1) CY1108046T1 (cg-RX-API-DMAC7.html)
DE (2) DE10235168A1 (cg-RX-API-DMAC7.html)
DK (1) DK1527097T3 (cg-RX-API-DMAC7.html)
ES (1) ES2297223T3 (cg-RX-API-DMAC7.html)
IL (1) IL166438A (cg-RX-API-DMAC7.html)
MX (1) MXPA05001042A (cg-RX-API-DMAC7.html)
PT (1) PT1527097E (cg-RX-API-DMAC7.html)
SI (1) SI1527097T1 (cg-RX-API-DMAC7.html)
WO (1) WO2004013176A1 (cg-RX-API-DMAC7.html)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428771B1 (en) * 1995-05-15 2002-08-06 Pharmaceutical Discovery Corporation Method for drug delivery to the pulmonary system
ES2395096T3 (es) * 1999-06-29 2013-02-08 Mannkind Corporation Purificación y estabilización de agentes farmacéuticos a base de péptidos y proteínas
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
JP4681231B2 (ja) 2002-03-20 2011-05-11 マンカインド コーポレイション 吸入装置
US7338171B2 (en) * 2003-10-27 2008-03-04 Jen-Chuen Hsieh Method and apparatus for visual drive control
US20050153874A1 (en) * 2004-01-12 2005-07-14 Mannkind Corporation Method of reducing serum proinsulin levels in type 2 diabetics
EP2106790B1 (en) * 2004-03-12 2012-10-24 Biodel, Inc. Rapid acting drug delivery compositions
US20080090753A1 (en) 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
HUE025151T2 (en) 2004-08-23 2016-01-28 Mannkind Corp Diceto-piperazine salts for drug delivery
MX373000B (es) 2005-09-14 2020-05-21 Mannkind Corp Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas.
US20070086952A1 (en) * 2005-09-29 2007-04-19 Biodel, Inc. Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
US8084420B2 (en) * 2005-09-29 2011-12-27 Biodel Inc. Rapid acting and long acting insulin combination formulations
US7713929B2 (en) 2006-04-12 2010-05-11 Biodel Inc. Rapid acting and long acting insulin combination formulations
CN104383546B (zh) 2006-02-22 2021-03-02 曼金德公司 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
WO2007121256A2 (en) * 2006-04-12 2007-10-25 Biodel, Inc. Rapid acting and long acting insulin combination formulations
WO2009089181A1 (en) * 2008-01-04 2009-07-16 Blodel, Inc. Insulin formulations for insulin release as a function of tissue glucose levels
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
MY155524A (en) 2008-06-13 2015-10-30 Mannkind Corp A dry powder inhaler and system for drug delivery
EP2609954B1 (en) 2008-06-20 2021-12-29 MannKind Corporation An interactive apparatus for real-time profiling of inhalation efforts
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9060927B2 (en) * 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
US8538707B2 (en) 2009-03-11 2013-09-17 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
AU2010259943C1 (en) 2009-06-12 2016-03-03 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
PH12011502708B1 (en) 2009-07-06 2017-11-10 Sanofi Aventis Deutschland Insulin preparations containing methionine
PL2464655T3 (pl) * 2009-08-11 2017-08-31 Biocon Limited Procesy chromatograficzne
JP5784622B2 (ja) 2009-11-03 2015-09-24 マンカインド コーポレ−ション 吸入活動をシミュレートするための装置及び方法
SG10201500871TA (en) 2009-11-13 2015-04-29 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
JP5832439B2 (ja) 2009-11-13 2015-12-16 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Glp−1アゴニスト、インスリン及びメチオニンを含む薬学的組成物
AU2011202239C1 (en) 2010-05-19 2017-03-16 Sanofi Long-acting formulations of insulins
RU2531455C2 (ru) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
CN103179978A (zh) 2010-08-30 2013-06-26 赛诺菲-安万特德国有限公司 Ave0010用于制造供治疗2型糖尿病用的药物的用途
AU2012213432B2 (en) 2011-02-01 2016-10-13 Novo Nordisk A/S Purification of insulin
DE102011003944A1 (de) 2011-02-10 2012-08-16 Oxprotect Gmbh Detektion und Entfernung von missgefalteten Proteinen/Peptiden
MX353285B (es) 2011-04-01 2018-01-05 Mannkind Corp Paquete de blister para cartuchos farmaceuticos.
CN102219851B (zh) * 2011-05-09 2012-05-30 甘李药业有限公司 甘精胰岛素结晶的制备方法
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
JP6367115B2 (ja) 2011-08-29 2018-08-01 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 2型糖尿病患者の血糖コントロールに使用する組合せ医薬
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
HK1201475A1 (en) 2011-10-24 2015-09-04 Mannkind Corporation Methods and compositions for treating pain
AU2013289957B2 (en) 2012-07-12 2017-02-23 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
US10421795B2 (en) * 2012-12-17 2019-09-24 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
BR112015023168B1 (pt) 2013-03-15 2021-08-10 Mannkind Corporation Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
EP3517122A1 (en) 2013-04-03 2019-07-31 Sanofi Treatment of diabetes mellitus by long-acting formulations of insulins
BR122019026637B1 (pt) 2013-07-18 2023-09-26 Mannkind Corporation Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
CA2954287C (en) * 2014-07-08 2020-12-22 Amphastar Pharmaceuticals, Inc. Methods of preparing inhalable micronized insulin for pulmonary delivery
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
US10322168B2 (en) 2016-01-07 2019-06-18 Amphastar Pharmaceuticals, Inc. High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
CN113773392B (zh) * 2020-06-09 2023-04-07 宁波鲲鹏生物科技有限公司 一种甘精胰岛素的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783441A (en) * 1979-04-30 1988-11-08 Hoechst Aktiengesellschaft Aqueous protein solutions stable to denaturation
CA1339955C (en) 1986-10-14 1998-07-14 Richard Eugene Heiney Process for transforming a human insulin precursor to human insulin
JPH0832726B2 (ja) * 1987-06-08 1996-03-29 武田薬品工業株式会社 ラットbFGFおよびその製造法
DE3726655A1 (de) * 1987-08-11 1989-02-23 Hoechst Ag Verfahren zur isolierung basischer proteine aus proteingemischen, welche solche basischen proteine enthalten
IL95495A (en) * 1989-08-29 1996-10-16 Hoechst Ag Fusion proteins their preparation and use
US5358857A (en) * 1989-08-29 1994-10-25 The General Hospital Corp. Method of preparing fusion proteins
JP2916206B2 (ja) * 1990-04-28 1999-07-05 帝國製薬株式会社 生理活性ペプチド
SG46612A1 (en) * 1992-12-02 1998-02-20 Hoechst Ag Process for obtaining proinsulin in processing correctly linked cystine bridges
US5886154A (en) * 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
DE19735711C2 (de) * 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
KR100253916B1 (ko) * 1997-12-29 2000-05-01 김충환 사람 인슐린 전구체의 제조방법
DE19947456A1 (de) * 1999-10-02 2001-04-05 Aventis Pharma Gmbh C-Peptid zur verbesserten Herstellung von Insulin und Insulinanaloga
HRP20020651B1 (en) * 2000-02-22 2011-01-31 Laboratoires Serono Sa Purified lh
DE10008064B4 (de) * 2000-02-22 2009-07-02 Siemens Ag Verfahren zum Anpassen der einem Turbo-Codierer zuzuführenden Datenblöcke und entsprechende Kommunikationsvorrichtung

Also Published As

Publication number Publication date
DK1527097T3 (da) 2008-05-26
ATE384742T1 (de) 2008-02-15
CA2493539C (en) 2012-01-31
US7803763B2 (en) 2010-09-28
BR0313131A (pt) 2005-07-05
US20060183666A1 (en) 2006-08-17
ES2297223T3 (es) 2008-05-01
DE50309087D1 (cg-RX-API-DMAC7.html) 2008-03-13
JP2006513978A (ja) 2006-04-27
CA2493539A1 (en) 2004-02-12
JP4519646B2 (ja) 2010-08-04
EP1527097A1 (de) 2005-05-04
AU2003254375A1 (en) 2004-02-23
AU2003254375B2 (en) 2009-01-08
IL166438A0 (en) 2006-01-15
CY1108046T1 (el) 2013-09-04
PT1527097E (pt) 2008-02-25
IL166438A (en) 2010-11-30
SI1527097T1 (sl) 2008-04-30
MXPA05001042A (es) 2005-04-08
US20050080000A1 (en) 2005-04-14
EP1527097B1 (de) 2008-01-23
WO2004013176A1 (de) 2004-02-12

Similar Documents

Publication Publication Date Title
EP1527097B1 (de) Verfahren zur reinigung von preproinsulin
DE60102899T2 (de) Verfahren zur lösung von glucagon-ähnlichen peptid-1 (glp-1) verbindungen
DE69029370T2 (de) Erythropoietin-Isoformen
DE69224858T2 (de) Essentiell reines menschliches Parathyroidhormon
DE69632224T2 (de) Reduzierung von Gelation von Fettsäureacylierten Proteinen unter Nutzung von Zitratpuffer
EP0763061B1 (de) Verfahren zur herstellung von cardiodilatin-fragmenten, hochgereinigte cardiodilatin-fragmente und zwischenprodukte zu deren herstellung
EP0980874B1 (de) Verbessertes Verfahren zur Gewinnung von Insulinvorläufern mit korrekt verbundenen Cystinbrücken
DE4405179A1 (de) Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
DE4435392B4 (de) Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF
EP1789445B1 (de) Verfahren zur entfernung von fibronektin aus plasmafraktionen
DE2600971A1 (de) Therapeutisches insulinpraeparat sowie verfahren zur herstellung eines stabilen insulinpraeparats mit dauerwirkung.
DE3650276T2 (de) Proteinreinigung.
EP1012191B1 (de) VERFAHREN ZUR GEWINNUNG VON HOCHREINEM vWF ODER FACTOR VIII/vWF-KOMPLEX
DE3611817A1 (de) Verfahren zur renaturierung von proteinen
EP0549915B1 (de) Neue synthetische Isohirudine mit verbesserter Stabilität
EP1959013B1 (de) Humanes zirkulierendes Virus inhibierendes Peptid (VIRIP) und seine Verwendung
EP1817338B1 (de) Herstellung eines von willenbrand faktor-präparates mit hoher spezifischer aktivität
DE19858777B4 (de) Verfahren zur teilweisen oder vollständigen Trennung von glykosilierten und nicht-glykosilierten Proteinen
DE69120409T2 (de) Verfahren zur reinigung von rekombinanten proteinen und dafür nützliche produkte
DE69207037T2 (de) Verfahren zum Umsetzen von Fusionsprotein in aktiven menschlichen motiunähnlichen Polypeptiden und Reinigung von diesen Analogen
DE4427531A1 (de) Humanes zirkulierendes beta-Defensin hBD-1
WO2006029773A1 (de) Herstellung eines von willebrand faktor-präparates unter verwendung von hydroxylapatit
DE19513784A1 (de) Hochreines Urodilatin und Verfahren zu seiner Herstellung
DE3129404A1 (de) Verfahren zur herstellung von einem b 30-threonin-insulin

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8127 New person/name/address of the applicant

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, 65929 FRANKFURT,

8130 Withdrawal